JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
$243.11
+8.35 (+3.56%)
Performance
1D
—
1W
+13.37%
1M
+12.16%
3M
-1.96%
6M
+4.64%
1Y
+82.53%
YTD
+40.40%
Open$236.31
Previous Close$234.76
Day High$243.20
Day Low$235.14
52W High$266.38
52W Low$128.80
Volume—
Avg Volume923.6K
Market Cap15.07B
P/E Ratio73.16
EPS$3.07
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$229.39
Above
SMA 200
$218.09
Above
RSI (14)
69.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-23.4% upside
Current
$243.11
$243.11
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.49B | 4.27B | 1.73B |
| Net Income | -374,819,438 | -320,480,233 | 500.28M |
| Profit Margin | -8.4% | -7.9% | 28.9% |
| EBITDA | 236.19M | 213.17M | 730.31M |
| Free Cash Flow | — | — | 376.40M |
| Rev Growth | +5.3% | +5.3% | +7.8% |
| Debt/Equity | 1.24 | 1.24 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,403.15 | +3.63% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.29 | +1.84% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $147.81 | +0.74% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.47 | +0.27% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.35 | +3.72% | 12.8 | 33.59B |